OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform


c Categories
p Projects
  • Highlighted
  • Trial protocol
  • Study Design
  • RCT
  • Cluster RCT
  • Observational
  • Model
  • Meta-analysis
  • Review
  • Guideline
  • Outcomes
  • Change patient management
  • Clinical outcomes
  • Economics
  • Operational efficiencies
  • Patient-centeredness
  • Safety
  • Guide Policy Making
  • Other
  • Uncategorized
  • Antibiotic Guidance
  • ACT Guided Heparinization
  • Cancer
  • COVID-19
  • Cardiovascular Disease
  • Diabetes
  • HIV POCT
  • Inflammatory Bowel Disease
  • Liver Disease
  • Kidney Disease
  • Newborn Screening
  • MALDI-TOF MS For Microorganism Identification
  • Preeclampsia
  • Pharmacogenetic and Pharmacogenomics
  • Therapeutic drug monitoring
  • Viscoelastic Testing

Please contact us for any suggestions



Zhen Zhao



Smeralda Skenderaj

Categories:Clinical outcomesGuide Policy MakingChange patient management
2 Publications found
  • Plasma EGFR mutation testing in non-small cell lung cancer: A value proposition.

    b
    Clinica chimica acta; international journal of clinical chemistry
    August 1, 2019
    p Cancer
    c Change patient management Clinical outcomes Economics Guide Policy Making Review
  • [The use of recombinant human B-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention].

    b
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
    November 1, 2010
    p Cardiovascular Disease
    c Change patient management Clinical outcomes Guide Policy Making RCT